LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Reply to: Burosumab for Tumor‐Induced Osteomalacia: not Enough of a Good Thing

Photo by kimberlyfarmer from unsplash

Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber, Munro Peacock, Karl Insogna, Rajiv Kumar, Frank Rauch, Diana Luca, Tricia Cimms, Mary Scott Roberts, Javier San Martin, and… Click to show full abstract

Suzanne M. Jan de Beur, Paul D. Miller, Thomas J. Weber, Munro Peacock, Karl Insogna, Rajiv Kumar, Frank Rauch, Diana Luca, Tricia Cimms, Mary Scott Roberts, Javier San Martin, and Thomas O. Carpenter Johns Hopkins University School of Medicine, Baltimore, MD, USA Colorado Center for Bone Research, Lakewood, CO, USA Duke University, Durham, NC, USA Indiana University School of Medicine, Indianapolis, IN, USA Yale University School of Medicine, New Haven, CT, USA Mayo Clinic College of Medicine, Rochester, MN, USA McGill University, Montreal, Canada Ultragenyx Pharmaceutical Inc., Novato, CA, USA

Keywords: burosumab tumor; university school; reply burosumab; medicine; university; school medicine

Journal Title: Journal of Bone and Mineral Research
Year Published: 2021

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.